Aspira Pathlab & Diagnostics Ltd — Important, 01-01-1970: Company Update

Aspira Pathlab & Diagnostics' Independent Director Committee has released its evaluation of the Open Offer from Mr. Arvind Karsandas Bhanushali and associated Acquirers. They intend to purchase up to 26.76 lakh equity shares, representing 26% of the company, at Rs. 55 per share in cash. The Committee finds the offer fair and reasonable, noting the Rs. 55 price aligns with market benchmarks and valuation parameters, particularly being the highest price paid by an acquirer in the last 26 weeks. This insight helps shareholders consider participation in the offer.